In Alzheimer disease (AD)–Salivary AChE activity may prove to be a useful marker of AD–associated changesin central cholinergic activity and the responsiveness of patients to treatment with AChE inhibitors [1]. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.